Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size.

Purpose of the present research work was to evaluate the biological distribution of differently size gold nanoparticles (NP) up on intravenous administration in mice. Another objective was to study effect of particle size on biological distribution of gold NP to enable their diverse applications in nanotechnology. Gold NP of different particle sizes, mainly 15, 50, 100 and 200 nm, were synthesized by modifying citrate ion concentration. Synthesized gold nanoparticles were characterized by SEM and their size distribution was studied by particle size analyzer. Gold NP was suspended in sodium alginate solution (0.5%, w/v) and administered to mice (1g/kg, intravenously) [n=3]. After 24h of administration of gold NP, blood was collected under light ether anesthesia, mice were sacrificed by cervical dislocation and various tissues/organs were removed. The tissues were then washed with saline, homogenized and lysed with aqua regia. The determination of gold in samples was carried out quantitatively by inductively coupled plasma mass spectrometry (ICP-MS). SEM study revealed spherical morphology of gold NP with narrow particle size distribution. Biodistribution study revealed gold NPs of all sizes were mainly accumulated in organs like liver, lung and spleen. The accumulation of gold NP in various tissues was found to be depending on particle size. 15 nm gold NP revealed higher amount of gold and number of particles in all the tissues including blood, liver, lung, spleen, kidney, brain, heart, stomach. Interestingly, 15 and 50 nm gold NP were able to pass blood-brain barrier as evident from gold concentration in brain. Two-hundred nanometers gold NP showed very minute presence in organs including blood, brain, stomach and pancreas. The results revealed that tissue distribution of gold nanoparticles is size-dependent with the smallest 15 nm nanoparticles showing the most widespread organ distribution.

[1]  Vincent M Rotello,et al.  Gold nanoparticle-mediated transfection of mammalian cells. , 2002, Bioconjugate chemistry.

[2]  J. Beesley.  Immunocytochemistry : a practical approach , 1993 .

[3]  J. Storhoff,et al.  A DNA-based method for rationally assembling nanoparticles into macroscopic materials , 1996, Nature.

[4]  S. Davis,et al.  Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating. , 1991, Biochemical and biophysical research communications.

[5]  Gert Storm,et al.  Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system , 1995 .

[6]  Sanjeev Kumar,et al.  Modeling of Formation of Gold Nanoparticles by Citrate Method , 2007 .

[7]  Hiroyuki Ohshima,et al.  In vitro permeation of gold nanoparticles through rat skin and rat intestine: effect of particle size. , 2008, Colloids and surfaces. B, Biointerfaces.

[8]  R M Albrecht,et al.  Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. , 2001, Journal of pharmaceutical sciences.

[9]  Robert Gurny,et al.  Drug-loaded nanoparticles : preparation methods and drug targeting issues , 1993 .

[10]  S. Davis,et al.  Biodistribution of poly(butyl 2-cyanoacrylate) nanoparticles in rabbits , 1986 .

[11]  Prashant V. Kamat,et al.  Photophysical, photochemical and photocatalytic aspects of metal nanoparticles , 2002 .

[12]  T. Niidome,et al.  Stabilizing of plasmid DNA in vivo by PEG-modified cationic gold nanoparticles and the gene expression assisted with electrical pulses. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Yokoyama Masayuki,et al.  Block copolymer micelles as vehicles for drug delivery , 1993 .

[14]  A. Maitra,et al.  Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles. , 2002, International journal of pharmaceutics.

[15]  J. Hillier,et al.  A study of the nucleation and growth processes in the synthesis of colloidal gold , 1951 .

[16]  Xiaohua Huang,et al.  Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. , 2006, Cancer letters.

[17]  Ji Guo,et al.  Nanofabricated particles for engineered drug therapies: a preliminary biodistribution study of PRINT nanoparticles. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[18]  Lisbeth Illum,et al.  Long circulating microparticulate drug carriers , 1995 .

[19]  S. Davis,et al.  Targeting of colloids to lymph nodes: influence of lymphatic physiology and colloidal characteristics , 1995 .

[20]  De‐Yin Wu,et al.  Surface-Enhanced Raman Scattering: From Noble to Transition Metals and from Rough Surfaces to Ordered Nanostructures , 2002 .

[21]  Takuro Niidome,et al.  PEG-modified gold nanorods with a stealth character for in vivo applications. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[22]  A. Maitra,et al.  Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system. , 2000, International journal of pharmaceutics.

[23]  Xiaohua Huang,et al.  Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer. , 2005, Nano letters.

[24]  T. Niidome,et al.  Preparation of primary amine-modified gold nanoparticles and their transfection ability into cultivated cells. , 2004, Chemical communications.

[25]  P. Couvreur,et al.  Lymphatic Targeting of Polymeric Nanoparticles After Intraperitoneal Administration in Rats , 1992, Pharmaceutical Research.

[26]  T. Davis,et al.  The Blood-Brain Barrier/Neurovascular Unit in Health and Disease , 2005, Pharmacological Reviews.

[27]  Kinam Park,et al.  Prevention of protein adsorption and platelet adhesion on surfaces by PEO/PPO/PEO triblock copolymers. , 1992, Biomaterials.

[28]  V. Torchilin,et al.  Which polymers can make nanoparticulate drug carriers long-circulating? , 1995 .

[29]  S. Sahoo,et al.  Nanotech approaches to drug delivery and imaging. , 2003, Drug discovery today.

[30]  R. Albrecht,et al.  Cytochalasin D and E: effects on fibrinogen receptor movement and cytoskeletal reorganization in fully spread, surface-activated platelets: a correlative light and electron microscopic investigation. , 1992, Blood.

[31]  V. Torchilin,et al.  Biodegradable long-circulating polymeric nanospheres. , 1994, Science.

[32]  C. J. Oss,et al.  Phagocytosis as a Surface Phenomenon , 1978 .

[33]  R. Müller,et al.  Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[34]  M. Sullivan,et al.  Development of a novel gene delivery scaffold utilizing colloidal gold–polyethylenimine conjugates for DNA condensation , 2003, Gene Therapy.

[35]  M. Huber,et al.  Gold nanoparticle probe-based gene expression analysis with unamplified total human RNA. , 2004, Nucleic acids research.

[36]  Shao-pu Liu,et al.  A study on the sizes and concentrations of gold nanoparticles by spectra of absorption, resonance Rayleigh scattering and resonance non-linear scattering. , 2005, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[37]  Y. Ikada,et al.  Protein Precoating of Polylactide Microspheres Containing a Lipophilic Immunopotentiator for Enhancement of Macrophage Phagocytosis and Activation , 1989, Pharmaceutical Research.

[38]  Teruo Okano,et al.  Polymeric micelles as new drug carriers , 1996 .

[39]  Alexander T. Florence,et al.  The Oral Absorption of Micro- and Nanoparticulates: Neither Exceptional Nor Unusual , 1997, Pharmaceutical Research.

[40]  S. Yamada,et al.  Facile Fabrication of Photoelectrochemical Assemblies Consisting of Gold Nanoparticles and a Tris(2,2‘-bipyridine)ruthenium(II)−Viologen Linked Thiol , 2001 .